TNF and rheumatoid arthritis: Others have also shown that the T2T strategy is underused in real clinical practice; e.g. in the analysis from the Corrona RA registry, a considerable proportion of patients continued without changing/accelerating treatment despite not reaching an adequate response to the initial TNF inhibitor therapy at 6 and 12 months [22].